基于Web of Science的“阿维菌素类药物”的文献计量研究  

A bibliometric study of the avermectin class of drugs based on the Web of Science

作　　者：文豪[1] 周绪正[1] 李冰[1] 牛建荣[1] 魏小娟[1] 张继瑜[1] 

机构地区：[1]中国农业科学院兰州畜牧与兽药研究所/农业部兽用药物创制重点实验室,兰州730050

出　　处：《黑龙江畜牧兽医》2016年第1期165-168,共4页Heilongjiang Animal Science And veterinary Medicine

基　　金：国家现代农业肉牛牦牛产业技术体系建设专项(CARS-38);传统中兽医药资源抢救和整理项目(2013FY110600-8)

摘　　要：为了了解全球范围内"阿维菌素类药物"的研究现状,文章采用文献计量研究的方法分析了Web of Science数据库中"阿维菌素类药物"的相关文献数据。结果表明:美国在"阿维菌素类药物"研究上发表了数量最多且质量最好的论文,我国与美国在"阿维菌素类药物"的研究上差距较大;默克公司等商业公司在"阿维菌素类药物"研究上也发表了较多的论文,间接体现出"阿维菌素类药物"的经济效益与实用意义。To understand the research status of the avermectin class of drugs on a global scale, this paper analyzes the relevant literature about the avermectin class of drugs in the database of the Web of Science using the method of bibliometric study. The results show that the USA has published the most and best papers about the avermectin class of drugs, and there is a large gap between the USA and China about the study of the avermectin class of drugs. The Merck company and some other business companies have also published many papers about the avermectin class of drugs, which indirectly reflects the economic benefits and practical significances of the avermectin class of drugs.

关 键 词：阿维菌素类药物 WEB of SCIENCE 文献计量 研究现状 论文 分析 

分 类 号：S859.796[农业科学—临床兽医学]